<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04611672</url>
  </required_header>
  <id_info>
    <org_study_id>PB_2016-01719</org_study_id>
    <nct_id>NCT04611672</nct_id>
  </id_info>
  <brief_title>Linearity and Non-linearity of Cerebral Autoregulation</brief_title>
  <official_title>Linearity and Non-linearity of Cerebral Autoregulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Injured brain tissue supplied by a disturbed state of cerebral autoregulation (CA) is at risk&#xD;
      of secondary ischemia, e.g. in patients with stroke, subarachnoid hemorrhage, intracerebral&#xD;
      hemorrhage or bacterial Meningitis. Up to now, there is lack of a simple and easy to perform&#xD;
      bed side test that would allow for to intervene when CA failure is indicated. For this&#xD;
      purpose, we explore the dynamics of the interplay between blood pressure and cerebral blood&#xD;
      flow velocity using transcranial Doppler ultrasound (or near infrared spectroscopy derived&#xD;
      haemoglobin concentration changes) as a measure of CA. To describe these dynamics different&#xD;
      mathematical models are used, but they all still need validation and proof of concept because&#xD;
      these dynamics are poorly understood with respect to the factors which influence the&#xD;
      composition of the mathematical models.&#xD;
&#xD;
      Objectives: To what amount is CA disturbed in the different stroke subgroups ? Is a disturbed&#xD;
      CA a risk factor of poorer outcome ?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We investigate which factors determine the dynamics of CA under the assumption that disturbed&#xD;
      dynamics of the relation blood pressure (BP) - cerebral blood flow velocity CBFv) indicate a&#xD;
      disturbed CA. Factors to be considered relevant are BP, blood carbon dioxide (CO2)&#xD;
      concentration (measured as endtidal CO2 concentration), autonomic nervous system function&#xD;
      such as heart rate, pulse pressure amplitude and baroreflex sensitivity, movement or&#xD;
      psychological tasks, and in the patients the kind and the severity of the underlying disease.&#xD;
      Via different mathematical models the effects of these variables on CBFv as the Output&#xD;
      function is evaluated. The most frequently used approach is the use of Transfer functions.&#xD;
&#xD;
      In the registry will include the patients with acute strokes hospitalized at our stroke&#xD;
      center. We will include every stroke patient with any Kind and severity of stroke syndromes&#xD;
      who gives informed consent and who has a so called temporal ultrasound window to insonate the&#xD;
      middle cerebral artery. BP will be measure noninvasively by a Finapres device. Items&#xD;
      registered are Age, gender, cerebrovascular risk factors, temperature, mean BP and ist&#xD;
      variability on days 1-3, stroke classification using TOAST, Perfusion Computed Tomography and&#xD;
      MRI, and at the time of the simultaneous recordings of CBFv and BP the endtidal CO2, mean BP,&#xD;
      mean pulsatility index, and after Transfer function analysis coherence, gain and Phase in&#xD;
      different frequency ranges&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 11, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Change of modified Rankin Scale (mRs) : 0, no symptoms. 1, no significant disability. 2, slight disability. 3, moderate disability. 4, moderate severe disability. 5, severe disability. 6, dead</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State of cerebral autoregulation (CA)</measure>
    <time_frame>Assessment on days 1-3 after stroke onset</time_frame>
    <description>Transfer function estimates (gain, phase) between low frequency oscillations in BP and CBFv. A low gain and a high phase indicate good CA, a high gain and a low phase a poor CA state. Typically, a phase of 1 radian indicates a good CA, a phase of 0.2 a very poor one.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">580</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Patients with stroke</arm_group_label>
    <description>Patients with stroke of all subtypes, with and without different Kind of Lysis therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Healthy controls of all Ages above 18 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Assessment of CA</intervention_name>
    <description>As part of our routine stroke work up, each patient receives an initial CT scan with CT perfusion to indicate thrombolysis therapy (intravenous, mechanical, or both, depending on the time since first stroke symptoms and perfusion-mismatch), an MRI within 2 days, extracranial and transcranial Duplex ultrasound, echocardiography, continuous Monitoring of BP, O2, body temperature, NIHSS and Glagow Coma Scale (GCS) every 6 hours. Assessing CA by continuous recording of blood pressure, cerebral blood flow velocity, end-tidal CO2. Analysis via Transfer function estimates</description>
    <arm_group_label>Patients with stroke</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Assesment of CA only</intervention_name>
    <description>Assessing CA by continuous recording of blood pressure, cerebral blood flow velocity, end-tidal CO2. Analysis via Transfer function estimates</description>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Stroke patients: all stroke patients which will be referred to our stroke Center aged 18&#xD;
        years or older. N=500.&#xD;
&#xD;
        Healthy controls of all ages above 18 years. N=80&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  every typ of ischemic stroke of any severity&#xD;
&#xD;
          -  presence of a &quot;temporal bone window&quot;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years,&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  no informed consent.&#xD;
&#xD;
          -  absence of a &quot;temporal bone window&quot;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Martin Müller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Luzerner Kantonsspital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Müller, MD</last_name>
    <phone>+41 41 205</phone>
    <phone_ext>5113</phone_ext>
    <email>martin.mueller@luks.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lehel Lakatos, MD</last_name>
    <phone>+41 41 205</phone>
    <phone_ext>6266</phone_ext>
    <email>Lehel-Barna.Lakatos@luks.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Luzern</name>
      <address>
        <city>Lucerne</city>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Müller, MD</last_name>
      <phone>+41 41 205</phone>
      <phone_ext>5133</phone_ext>
      <email>martin.mueller@luks.ch</email>
    </contact>
    <contact_backup>
      <last_name>Lehel Lakatos, MD</last_name>
      <phone>+41 41 205</phone>
      <phone_ext>6266</phone_ext>
      <email>Lehel-Barna.Lakatos@luks.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Beishon L, Minhas JS, Nogueira R, Castro P, Budgeon C, Aries M, Payne S, Robinson TG, Panerai RB. INFOMATAS multi-center systematic review and meta-analysis individual patient data of dynamic cerebral autoregulation in ischemic stroke. Int J Stroke. 2020 Oct;15(7):807-812. doi: 10.1177/1747493020907003. Epub 2020 Feb 24.</citation>
    <PMID>32090712</PMID>
  </reference>
  <reference>
    <citation>Meel-van den Abeelen AS, Simpson DM, Wang LJ, Slump CH, Zhang R, Tarumi T, Rickards CA, Payne S, Mitsis GD, Kostoglou K, Marmarelis V, Shin D, Tzeng YC, Ainslie PN, Gommer E, Müller M, Dorado AC, Smielewski P, Yelicich B, Puppo C, Liu X, Czosnyka M, Wang CY, Novak V, Panerai RB, Claassen JA. Between-centre variability in transfer function analysis, a widely used method for linear quantification of the dynamic pressure-flow relation: the CARNet study. Med Eng Phys. 2014 May;36(5):620-7. doi: 10.1016/j.medengphy.2014.02.002. Epub 2014 Apr 13.</citation>
    <PMID>24725709</PMID>
  </reference>
  <reference>
    <citation>Claassen JA, Meel-van den Abeelen AS, Simpson DM, Panerai RB; international Cerebral Autoregulation Research Network (CARNet). Transfer function analysis of dynamic cerebral autoregulation: A white paper from the International Cerebral Autoregulation Research Network. J Cereb Blood Flow Metab. 2016 Apr;36(4):665-80. doi: 10.1177/0271678X15626425. Epub 2016 Jan 18. Review.</citation>
    <PMID>26782760</PMID>
  </reference>
  <results_reference>
    <citation>Müller M, Österreich M, Lakatos L, Hessling AV. Cerebral macro- and microcirculatory blood flow dynamics in successfully treated chronic hypertensive patients with and without white mater lesions. Sci Rep. 2020 Jun 8;10(1):9213. doi: 10.1038/s41598-020-66317-x.</citation>
    <PMID>32514031</PMID>
  </results_reference>
  <results_reference>
    <citation>Müller M, Österreich M, von Hessling A, Smith RS. Incomplete recovery of cerebral blood flow dynamics in sufficiently treated high blood pressure. J Hypertens. 2019 Feb;37(2):372-379. doi: 10.1097/HJH.0000000000001854.</citation>
    <PMID>29995701</PMID>
  </results_reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 21, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>October 27, 2020</last_update_submitted>
  <last_update_submitted_qc>October 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Luzerner Kantonsspital</investigator_affiliation>
    <investigator_full_name>Martin Müller</investigator_full_name>
    <investigator_title>Prof Dr med</investigator_title>
  </responsible_party>
  <keyword>Stroke, Cerebral autoregulation, Doppler, Carotid disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>retrospective data collection for an individual participant data metaanalysis as published in Int J Stroke. 2020 Oct;15(7):807-812. doi: 10.1177/1747493020907003</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>2021 - 2025</ipd_time_frame>
    <ipd_access_criteria>on request to M Müller</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

